Announcements
C19 Rapid Review initiative
Genome Medicine has joined the C19 Rapid Review initiative, a cross-publisher collaboration to ensure that COVID-19 research is reviewed and published as quickly and openly as possible. Learn morehere.
Submissions from medRxiv
Authors are now able to submit manuscripts toGenome Medicinedirectly from medRxiv without having to re-upload files.
Portable peer review
To reduce time spent on serial submissions and iterative reviewing,Genome Medicineoffers to consider manuscripts on the basis of reviews received at other journals. We also support transfers of reviews obtained atGenome Medicineto other journals, including those outside of BMC and Springer Nature. Learn more from ourpeer review policy page.
COVID-19 submissions
In response to the current SARS-CoV-2 pandemicGenome Medicineeditors will treat relevant submissions with high priority.